WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr | ₹2.88 Cr | ₹7.87 Cr |
What is the latest Total Non-Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹3.44 Cr |
Mar2022 | ₹0.21 Cr |
Mar2021 | ₹3.59 Cr |
Mar2020 | ₹2.88 Cr |
Mar2019 | ₹7.87 Cr |
How is Total Non-Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹3.44 Cr | 1,513.62 | |
Mar2022 | ₹0.21 Cr | -94.06 | |
Mar2021 | ₹3.59 Cr | 24.61 | |
Mar2020 | ₹2.88 Cr | -63.44 | |
Mar2019 | ₹7.87 Cr | - |
Compare Total Non-Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,148.0 Cr | -0.6% | 5.6% | 118.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -0.6% |
5.6% |
118.2% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses